In a pivotal moment for the American cannabis sector, the U.S. Department of Health and Human Services (HHS) has proposed a reclassification of cannabis to the DEA. This could shift cannabis from its current Schedule I status, bringing potential upheaval in the perception and market dynamics of the plant.
Researchers applaud health officials' push to ease cannabis restrictions | Science science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter. #ACB #alvarezandMarsal #AuroraCannabis
DEA-Licensed Pharmaceutical Cannabis Company Biopharmaceutical Research Company (BRC) Announces $20M Series A Funding Round. The Company. #BiopharmaceuticalResearchCompany #IntrinsicCapitalPartners
/PRNewswire/ Biopharmaceutical Research Company ("BRC"), an active Drug Enforcement Administration (DEA) pharmaceutical cannabis license holder, announced.